Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
With examinations of 19 new psychiatric drugs, 19 new forms of previously available drugs, and a host of new medical agents, this third edition of the Clinical Manual of Psychopharmacology in the Medically Ill has been updated to include medical and psychiatric drugs that have become available since the publication of the second edition in 2017, as well as recent relevant randomized controlled trials, systematic reviews, and meta-analyses.
Boasting all the rigor that characterized the preceding editions, every chapter in this new volume has been reviewed and revised by experts—including 11 new authors. For 15 categories of medical disorders and specialty areas that include cardiovascular disorders, oncology, obstetrics and gynecology, and substance use disorders, the book examines
• Key differential diagnostic considerations
• The evidence for the efficacy of psychiatric drugs in each disorder
• Disease-specific side effects of psychiatric drugs
• Neuropsychiatric side effects of drugs for each medical disorder
• Disease-specific alterations in pharmacokinetics
• Drug-drug interactions
Patients with medical and psychiatric comorbidity have more functional impairment, disability days, emergency department use, and rehospitalization, as well as higher medical care costs. By examining the intersection of psychiatric and medical illness, and offering easily referenced key points for each chapter, this new edition prepares both mental health practitioners and primary care physicians and internists to more safely and effectively work with patients who have psychiatric and medical illness.
his book is a comprehensive review of information regarding pharmacodynamics and drug-drug interactions of psychiatric and non-psychiatric medicines related to medical disorders. Regardless of clinical setting, many patients are being treated for other medical illnesses. The book covers important issues clinicians should be aware of in treating these patients. The information covered will be useful to all prescribers in the mental health field and especially those who see patients with more severe or complicated medical problems such as those seen in hospital practices.
— Michael Easton, MD
James L. Levenson, M.D., is Rhona Arenstein Professor of Psychiatry, Professor of Medicine and Surgery, Chair of the Division of Consultation-Liaison Psychiatry, and Vice-Chair in the Department of Psychiatry at Virginia Commonwealth University School of Medicine in Richmond, Virginia.
Stephen J. Ferrando, M.D., is Director of the Department of Psychiatry at Westchester Medical Center Health System and Edith Har Esh, M.D., Professor and Chairman in the Department of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York.
Part I: General Principles
Chapter 1. Pharmacokinetics, Pharmacodynamics, and Principles of Drug-Drug Interactions
Chapter 2. Severe Drug Reactions
Chapter 3. Alternative Routes of Drug Administration
Part II: Psychopharmacology in Organ System Disorders and Specialty Areas
Chapter 4. Gastrointestinal Disorders
Chapter 5. Renal and Urological Disorders
Chapter 6. Cardiovascular Disorders
Chapter 7. Respiratory Disorders
Chapter 8. Oncology
Chapter 9. Central Nervous System Disorders
Chapter 10. Endocrine and Metabolic Disorders
Chapter 11. Obstetrics and Gynecology
Chapter 12. Infectious Diseases
Chapter 13. Dermatological Disorders
Chapter 14. Rheumatological Disorders
Chapter 15. Surgery and Critical Care
Chapter 16. Organ Transplantation
Chapter 17. Pain Management
Chapter 18. Substance Use Disorders